Skip to content

Effectiveness of ultrasound-guided trigger point therapy in patients with nonspecific neck pain of the upper trapezius

Effectiveness of ultrasound-guided trigger point therapy in patients with nonspecific neck pain of the upper trapezius

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051009
Enrollment
Unknown
Registered
2021-09-10
Start date
2021-09-11
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonspecific neck pain

Interventions

trigger point injection (TPI) group and the control group:trigger point injection (TPI) therapy and standard care

Sponsors

Department of Rehabilitation Medicine, the Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male and female patients aged 20-65; neck musculoskeletal pain, neck pain greater than or equal to VAS score of 3 points; pain in neck muscles and surrounding tissues for more than 3 months; 2. At least one trigger point can be found in the neck, a cord-like nodule can be palpated, and the form of referred pain should be consistent with the trigger point tenderness; pain can lead to a reduction in the range of motion of the neck and shoulders; 3. Mental stress or lack of sleep can exacerbate pain.

Exclusion criteria

Exclusion criteria: 1. The patient has been diagnosed with temporomandibular arthritis or fibromyalgia; uncontrollable pain or other discomfort during treatment; 2. Excessive muscle tension or mental anxiety during injection therapy; severe swelling and bleeding after injection therapy; neck pain not caused by myofascial trigger points (such as rheumatoid arthritis, spondylolisthesis, previous cervical spine surgery) , fibromyalgia, thyroid disease, etc.) severe dizziness or severe postural disturbances; 3. Other conditions that are not suitable for injection therapy: such as local skin infection, skin ulceration, use of anticoagulant drugs; other factors affecting the assessment results: such as alcohol and drug abuse; cognitive or communication dysfunction.

Design outcomes

Primary

MeasureTime frame
visual analog scale (VAS) score;

Countries

China

Contacts

Public ContactWang Sanrong

Chongqing Medical University

710147996@qq.com+86 15902310491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026